These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 38335308)
21. Enhanced ROS-Boosted Phototherapy against Pancreatic Cancer Tao W; Wang N; Ruan J; Cheng X; Fan L; Zhang P; Lu C; Hu Y; Che C; Sun D; Duan J; Zhao M ACS Appl Mater Interfaces; 2022 Feb; 14(5):6404-6416. PubMed ID: 35077153 [No Abstract] [Full Text] [Related]
22. Nrf2/FSP1/CoQ10 axis-mediated ferroptosis is involved in sodium aescinate-induced nephrotoxicity. Zhu H; Yang Y; Duan Y; Zheng X; Lin Z; Zhou J Arch Biochem Biophys; 2024 Sep; 759():110100. PubMed ID: 39033970 [TBL] [Abstract][Full Text] [Related]
23. Smart Nanoreactors for pH-Responsive Tumor Homing, Mitochondria-Targeting, and Enhanced Photodynamic-Immunotherapy of Cancer. Yang G; Xu L; Xu J; Zhang R; Song G; Chao Y; Feng L; Han F; Dong Z; Li B; Liu Z Nano Lett; 2018 Apr; 18(4):2475-2484. PubMed ID: 29565139 [TBL] [Abstract][Full Text] [Related]
24. Ferroptosis triggered by dihydroartemisinin facilitates chlorin e6 induced photodynamic therapy against lung cancerthrough inhibiting GPX4 and enhancing ROS. Han N; Li LG; Peng XC; Ma QL; Yang ZY; Wang XY; Li J; Li QR; Yu TT; Xu HZ; Xu X; Chen X; Wang MF; Li TF Eur J Pharmacol; 2022 Mar; 919():174797. PubMed ID: 35122867 [TBL] [Abstract][Full Text] [Related]
25. Capsaicin Enhanced the Efficacy of Photodynamic Therapy Against Osteosarcoma via a Pro-Death Strategy by Inducing Ferroptosis and Alleviating Hypoxia. Wang Y; Zhou X; Yao L; Hu Q; Liu H; Zhao G; Wang K; Zeng J; Sun M; Lv C Small; 2024 Jun; 20(26):e2306916. PubMed ID: 38221813 [TBL] [Abstract][Full Text] [Related]
26. FSP1-mediated ferroptosis in cancer: from mechanisms to therapeutic applications. Gao R; Wang J; Huang J; Wang T; Guo L; Liu W; Guan J; Liang D; Meng Q; Pan H Apoptosis; 2024 Aug; 29(7-8):1019-1037. PubMed ID: 38615304 [TBL] [Abstract][Full Text] [Related]
27. Engineering nanoenzymes integrating Iron-based metal organic frameworks with Pt nanoparticles for enhanced Photodynamic-Ferroptosis therapy. Ye Y; Yu H; Chen B; Zhao Y; Lv B; Xue G; Sun Y; Cao J J Colloid Interface Sci; 2023 Sep; 645():882-894. PubMed ID: 37178565 [TBL] [Abstract][Full Text] [Related]
28. Induction of ferroptosis by photodynamic therapy and enhancement of antitumor effect with ferroptosis inducers. Kojima Y; Tanaka M; Sasaki M; Ozeki K; Shimura T; Kubota E; Kataoka H J Gastroenterol; 2024 Feb; 59(2):81-94. PubMed ID: 37947872 [TBL] [Abstract][Full Text] [Related]
29. Aggregation-Induced Emission Photosensitizer-Engineered Anticancer Nanomedicine for Synergistic Chemo/Chemodynamic/Photodynamic Therapy. Yu B; Liu M; Jiang L; Xu C; Hu H; Huang T; Xu D; Wang N; Li Q; Tang BZ; Huang X; Zhang W Adv Healthc Mater; 2024 Apr; 13(11):e2303643. PubMed ID: 38115727 [TBL] [Abstract][Full Text] [Related]
30. Enhanced Photodynamic Therapy Synergizing with Inhibition of Tumor Neutrophil Ferroptosis Boosts Anti-PD-1 Therapy of Gastric Cancer. Zhu X; Zheng W; Wang X; Li Z; Shen X; Chen Q; Lu Y; Chen K; Ai S; Zhu Y; Guan W; Yao S; Liu S Adv Sci (Weinh); 2024 Mar; 11(12):e2307870. PubMed ID: 38233204 [TBL] [Abstract][Full Text] [Related]
31. 5-ALA-PDT induced ferroptosis in keloid fibroblasts via ROS, accompanied by downregulation of xCT, GPX4. Zhang J; Liu L; Li X; Shen X; Yang G; Deng Y; Hu Z; Zhang J; Lu Y Photodiagnosis Photodyn Ther; 2023 Jun; 42():103612. PubMed ID: 37220842 [TBL] [Abstract][Full Text] [Related]
32. Light triggered release of a triple action porphyrin-cisplatin conjugate evokes stronger immunogenic cell death for chemotherapy, photodynamic therapy and cancer immunotherapy. Song H; Cai Z; Li J; Xiao H; Qi R; Zheng M J Nanobiotechnology; 2022 Jul; 20(1):329. PubMed ID: 35842642 [TBL] [Abstract][Full Text] [Related]
33. Acidity-activatable dynamic hybrid nanoplatforms derived from extracellular vesicles of M1 macrophages enhance cancer immunotherapy through synergistic triple immunotherapy. Guo Y; Lv T; Li Z; Wei X; Yang C; Li W; Hou X; Wang Z; Qian R J Nanobiotechnology; 2024 Jul; 22(1):430. PubMed ID: 39033108 [TBL] [Abstract][Full Text] [Related]
34. ROS-responsive self-activatable photosensitizing agent for photodynamic-immunotherapy of cancer. Wang N; Zhao Z; Xiao X; Mo L; Yao W; Yang H; Wang J; Wei X; Yuan Y; Yang R; Jiang X Acta Biomater; 2023 Jul; 164():511-521. PubMed ID: 37004782 [TBL] [Abstract][Full Text] [Related]
35. [Comparison of three commercial photosensitizers for efficiency of inducing immunogenic cell death in anti-tumor immunotherapy]. Lin X; Mao D; Bai R Nan Fang Yi Ke Da Xue Xue Bao; 2022 Dec; 42(12):1791-1798. PubMed ID: 36651246 [TBL] [Abstract][Full Text] [Related]
36. Efficient NIR-II Type-I AIE Photosensitizer for Mitochondria-Targeted Photodynamic Therapy through Synergistic Apoptosis-Ferroptosis. Zhuang J; Wang B; Chen H; Zhang K; Li N; Zhao N; Tang BZ ACS Nano; 2023 May; 17(10):9110-9125. PubMed ID: 37144959 [TBL] [Abstract][Full Text] [Related]
37. Enhanced Ferroptosis by Oxygen-Boosted Phototherapy Based on a 2-in-1 Nanoplatform of Ferrous Hemoglobin for Tumor Synergistic Therapy. Xu T; Ma Y; Yuan Q; Hu H; Hu X; Qian Z; Rolle JK; Gu Y; Li S ACS Nano; 2020 Mar; 14(3):3414-3425. PubMed ID: 32155051 [TBL] [Abstract][Full Text] [Related]
38. FSP1 inhibition enhances olaparib sensitivity in BRCA-proficient ovarian cancer patients via a nonferroptosis mechanism. Miao H; Meng H; Zhang Y; Chen T; Zhang L; Cheng W Cell Death Differ; 2024 Apr; 31(4):497-510. PubMed ID: 38374229 [TBL] [Abstract][Full Text] [Related]
39. pH-activated nanoplatform for visualized photodynamic and ferroptosis synergistic therapy of tumors. Sun R; Ma W; Ling M; Tang C; Zhong M; Dai J; Zhu M; Cai X; Li G; Xu Q; Tang L; Yu Z; Peng Z J Control Release; 2022 Oct; 350():525-537. PubMed ID: 36055597 [TBL] [Abstract][Full Text] [Related]
40. Developing Hypoxia-Sensitive System via Designing Tumor-Targeted Fullerene-Based Photosensitizer for Multimodal Therapy of Deep Tumor. Li L; Fu J; Ye J; Liu L; Sun Z; Wang H; Tan S; Zhen M; Wang C; Bai C Adv Mater; 2024 Jun; 36(23):e2310875. PubMed ID: 38450765 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]